Skip to content

Released Aug 6, 2018, after the close

10-Q filed Aug 6, 2018, 37 days after period end · 0001558370-18-006445

Q2 2018 · 10-Q
Revenue$81.11M+24.6% vs Q2 2017+17.3% vs Q1 2018
Net Income-$49.38MN/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.32N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$14,677,000N/M
Operating Cash Flowderived-$22,691,000N/M
Free Cash Flowderived-$22,629,000N/M
Margins · derived
Operating margin-18.1%+44.9 pt vs Q2 2017
Net margin-60.9%+7.1 pt vs Q2 2017

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2018Q2 2017Q2 2016Q2 2015
Revenue$81.11M$65.08M$54.35M$27.74M
Net Income-$49.38M-$44.22M-$21.70M—
EPS Diluted-$0.32-$0.30-$0.15-$0.34

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR